Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Insmed's (INSM) CEO Will Lewis on Q4 2017 Results - Earnings Call Transcript

23h seekingalpha
Good day, ladies and gentlemen, and welcome to the Insmed fourth quarter 2017 financial results conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions]. As a reminder, this conference call is being recorded. (25-0)

Hercules Capital (HTGC) Q4 Earnings In Line, Revenues Rise

2018-02-23 zacks
Hercules Capital, Inc.’s (HTGC - Free Report) fourth-quarter 2017 net investment income (NII) of 29 cents per share was in line with the Zacks Consensus Estimate. However, the figure declined 32.6% from the year-ago quarter. This includes the one-time impact of the 2024 Notes redemption plus the non-recurring interest overlap due to the 30-day redemption period. Results reflected higher revenues, growth in investment portfolio and a rise in net asset value. (63-0)

Hercules Capital's (HTGC) CEO Manuel Henriquez on Q4 2017 Results - Earnings Call Transcript

2018-02-23 seekingalpha
Good day, ladies and gentlemen, and welcome to the Hercules Capital Fourth Quarter and Full Year 2017 Financial Results Conference Call. [Operator Instructions]. As a reminder, this conference call is being recorded. (46-0)

HTGC / Hercules Capital, Inc. FORM 8-K (Current Report)

Form 8-K     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):     February 20, 2018     Hercules Capital, Inc. (Exact name of registrant as specified in its charter)       Maryland   814-00702   74-3113410 (State or other jurisdiction of incorporation)   (Commission File No. (2-0)

HTGC / Hercules Capital, Inc. 10-K (Annual Report)

htgc-10k_20171231.htm   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 10-K   (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from        to         Commission File No. (2-0)

LendingClub (LC) Q4 Earnings: What's in Store for the Stock?

2018-02-16 zacks
LendingClub Corporation (LC - Free Report) is slated to announce fourth-quarter and 2017 results on Feb 20, after the market closes. Its quarterly earnings and revenues are projected to grow year over year. Last quarter, the company reported adjusted earnings per share of 3 cents, which met the Zacks Consensus Estimate. While the quarter witnessed higher revenues, an increase in expenses and fall in loan balance were the undermining factors. (28-2)

Ares Capital (ARCC) Stock Gains 3.2% on Q4 Earnings Beat

2018-02-15 zacks
Shares of Ares Capital Corporation (ARCC - Free Report) have rallied 3.2% since the release of its fourth quarter and 2017 results, early this week. The company’s fourth-quarter core earnings of 38 cents per share beat the Zacks Consensus Estimate by a penny. However, the bottom line declined 9.5% from the year-ago quarter. Results reflected improved revenues and solid portfolio activity. However, significant increase in expenses was the headwind. (60-0)

Concert Pharmaceuticals: Expecting Upside From Here

2018-02-14 seekingalpha
Shares have risen substantially since presenting the idea to readers initially. However, it's been a loser since my last update piece. (24-1)

Ares Capital: 10% Yield And What To Watch For This Week

2018-02-12 seekingalpha
This article discusses many of the key indicators that I am looking for in Q4 2017 and some of the highlights from Q3. (18-0)

Moody's (MCO) Beats Q4 Earnings & Revenues, Issues '18 View

2018-02-09 zacks
Moody's Corporation (MCO - Free Report) reported fourth-quarter 2017 adjusted earnings of $1.51 per share, which handily surpassed the Zacks Consensus Estimate of $1.45. Also, the bottom line improved 20% from the year-ago quarter. Results were attributable to impressive revenue growth, reflecting strong issuance in the quarter. Also, both Moody’s Investors Service and Moody’s Analytics segments witnessed improved performance. (29-0)

5 Rock-Solid Dividend Stocks Yielding 7% and Higher

2018-02-08 investorplace
With the dividend yield of the S&P 500 sitting at a measly 1.9% and U.S. Treasury yields for 10-year bonds sitting fractionally higher at 2.2%, investors seeking dividend yields want higher rates. (191-3)

Will Rise in Bond Issuance Drive Moody's (MCO) Q4 Earnings?

2018-02-07 zacks
Moody's Corporation (MCO - Free Report) is scheduled to report fourth quarter and 2017 results on Feb 9, before the opening bell. The company is expected to witness a year-over-year rise in revenues in its Corporate Finance line, the largest revenue contributor at the Moody's Investors Service (“MIS”) division. Backdrop for bond issuance (driven by tightening of credit spreads and a rise in long-term yield curve) during the fourth quarter was favorable. (41-0)

Verastem: Updates To Thesis

2018-01-28 seekingalpha
Dilution occurred as predicted, although the amount was less than I would have thought in this case. (117-4)

Concert Pharmaceuticals Is In A Major Jam: Where To Next?

2018-01-18 seekingalpha
Concert falls after losing an initial patent battle in court for its CTP-543 drug candidate, but it creates a nice buying opportunity. (10-0)

CUSIP: 427096508